Helicobacter pylori in gastric malignancies

Current Gastroenterology Reports

Volumn 14, Issue 6, 2012, Pages 489-496

  Bhandari, Abhishek ^a   Crowe, Sheila E ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Adenocarcinoma .MALT; Cancer; Gastric; Helicobacter; Lymphoma; Malignancy; Mucosa associated lymphoid tissue; Pylori; Stomach

Indexed keywords

CAGA PROTEIN; HELICOBACTER PYLORI VACCINE;

BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER INVASION; CANCER RISK; CANCER STAGING; CELLULAR IMMUNITY; DISEASE COURSE; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; ERADICATION THERAPY; GASTRECTOMY; GASTROSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOCYTOCHEMISTRY; MALIGNANT TRANSFORMATION; MARGINAL ZONE LYMPHOMA; MICROBIAL ACTIVITY; NONHUMAN; OBESITY; OXIDATIVE STRESS; REGULATORY MECHANISM; REMISSION; REVIEW; STOMACH ADENOCARCINOMA; STOMACH ATROPHY; STOMACH BIOPSY; STOMACH CARCINOGENESIS; STOMACH EPITHELIUM; STOMACH LYMPHOMA; STOMACH ULCER; VACCINATION;

ADENOCARCINOMA; CELL TRANSFORMATION, NEOPLASTIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LYMPHOMA, B-CELL, MARGINAL ZONE; RISK FACTORS; STOMACH NEOPLASMS;

EID: 84870507656     PISSN: 15228037     EISSN: 1534312X     Source Type: Journal    
DOI: 10.1007/s11894-012-0296-y     Document Type: Review

References (69)

1. McColl KEL. Helicobacter pylori infection. NEJM. 2010;362:1597-604
2. Pounder RE, Ng D. The prevalence of Helicobacter pylori infection in different countries. Aliment Pharmacol Ther. 1995;9(Supp 2):33
3. Graham DY, Schwartz JT, Cain GD, Gyorkey F. Prospective evaluation of biopsy number in the diagnosis of esophageal and gastric carcinoma. Gastroenterology. 1982;82(2):228
4. Japanese Research Society for Gastric Cancer: The General Rules for the Gastric Cancer Study in Surgery and Pathology. Kanahara Shuppan 1993
5. Edge SB, Byrd DR, Compton CC, et al.: American Joint Committee on Cancer Staging Manual 2010. 117
6. Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer. 1972;29(1):252
7. Isaacson PG: Gastrointestinal lymphomas and lymphoid hyperplasias. Neoplastic Haematolpathology 1992:953
8. de Martel C, Ferlay J, Franceschi S, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol. 2012;13(6):607-15. This is an interesting report indicating that of the 12.7 million new cancers occurring in 2008, the population attributable fraction due to infection was over 16% with H. pylori, hepatitis B and C and human papilloma virus responsible for 1.9 million cases. The fraction was higher (almost 23%) in the less developed world
9. The EUROGAST Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet. 1993;341(8857):1359
10. Huang JQ, Sridhar S, Chen Y, et al. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology. 1998;114(6):1169
11. Hansson LR, Engstrand L, Nyrén O, et al. Prevalence of Helicobacter pylori infection in subtypes of gastric cancer. Gastroenterology. 1995;109(3):885
12. Kamada T, Kurose H, Yamanka Y, et al. Relationship between Gastroesophageal Junction Adenocarcinoma and Helicobacter pylori Infection in Japan. Digestion. 2012;85(4):256-60
13. Tsugane S, Tei Y, Takahashi T, et al. Salty food intake and risk of Helicobacter pylori infection. Jpn J Cancer Res. 1994;85:474
14. González CA, López-Carrillo L. Helicobacter pylori, nutrition and smoking interactions: their impact in gastric carcinogenesis. Scand J Gastroenterol. 2010;45:6
15. Iida M, Ikeda F, Ninomiya T, et al. White blood cell count and risk of gastric cancer incidence in a general Japanese population: the Hisayama study. Am J Epid. 2012;175(6):504-10
16. Cho Y, Lee DH, Oh HS, et al.: Higher Prevalence of Obesity in Gastric Cardia Adenocarcinoma Compared to Gastric Non-Cardia Adenocarcinoma. Digestive Diseases and Sciences 2012
17. Li Q, Zhang J, Zhou YN, Qiao L. Obesity and gastric cancer. Front biosci: j virtual library. 2012;17:2383-90
18. Ikeda F, Doi Y, Yonemoto K, et al. Hyperglycemia increases risk of gastric cancer posed by Helicobacter pylori infection: a populationbased cohort study. Gastroenterology. 2009;136(4):1234-41
19. Sokolova O, Vieth M, Naumann M: Protein kinase C isozymes regulate matrix metalloproteinase-1 expression and cell invasion in Helicobacter pylori infection. Gut 2012
20. Moss SF, Calam J, Agarwal B, et al. Induction of gastric epithelial apoptosis by Helicobacter pylori. Gut. 1996;38:498
21. Jones NL, Day AS, Jennings HA, et al. Helicobacter pylori induces gastric epithelial cell apoptosis in association with increased Fas receptor expression. Infect Immun. 1999;67:4237
22. Correa P, Miller MJ. Helicobacter pylori and gastric atrophy-cancer paradoxes. J Natl Cancer Inst. 1995;87:1731
23. Lauwers GY, Scott GV, Hendricks J. Immunohistochemical evidence of aberrant bcl-2 protein expression in gastric epithelial dysplasia. Cancer. 1994;73:2900
24. Müller A. Multistep activation of the Helicobacter pylori effector CagA. J Clin Invest. 2012;122(4):1192-5
25. Raju D, Hussey S, Ang M, et al. Vacuolating cytotoxin and variants in Atg16L1 that disrupt autophagy promote Helicobacter pylori infection in humans. Gastroenterology. 2012;142(5):1160-71
26. Buti L, Spooner E, Van der Veen AG, et al. Helicobacter pylori cytotoxin-associated gene A (CagA) subverts the apoptosisstimulating protein of p53 (ASPP2) tumor suppressor pathway of the host. Proc Natl Acad Sci USA. 2011;108(22):9238-43
27. Li Z, Chen J, Chan KW, et al. A possible role of cIAP2 in Helicobacter pylori-associated gastric cancer. Cancer Lett. 2011;313(2):192-200
28. Saito M, Suzuki K, Maeda T, et al. The accumulation of DNA demethylation in Sat a in normal gastric tissues with Helicobacter pylori infection renders susceptibility to gastric cancer in some individuals. Oncology Rep. 2012;27(6):1717-25
29. Chaturvedi R, Asim M, Romero-Gallo J, et al. Spermine oxidase mediates the gastric cancer risk associated with Helicobacter pylori CagA. Gastroenterology. 2011;141(5):1696-708
30. Silva-Fernandes IJ, da Silva TA, Agnez-Lima LF, et al. Helicobacter pylori genotype and polymorphisms in DNA repair enzymes: Where do they correlate in gastric cancer? J Surg Oncol. 2012;106(4):448-55
31. Chattopadhyay R, Bhattacharyya A, Crowe SE. Dual regulation by apurinic/apyrimidinic endonuclease-1 inhibits gastric epithelial cell apoptosis during Helicobacter pylori infection. Cancer Res. 2010;70(7):2799-808
32. Lu XX, Yu JL, Ying LS, et al.: Stepwise cumulation of RUNX3 methylation mediated by Helicobacter pylori infection contributes to gastric carcinoma progression. Cancer 2012
33. KwonHJ, WonYS, NamKT, et al.Vitamin D3 upregulated protein 1 deficiency promotes N-methyl-N-nitrosourea and Helicobacter pyloriinduced gastric carcinogenesis in mice. Gut. 2012;61(1):53-63
34. Ohnishi N, Yuasa H, Tanaka S, et al. Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proc Natl Acad Sci USA. 2008;105:1003
35. Talebi B, Abadi A, Rafiei A, et al. Helicobacter pylori homB, but not cagA, is associated with gastric cancer in Iran. J Clin Microbiol. 2011;49(9):3191-7
36. Figueiredo C, Machado JC, Pharoah P, et al. Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst. 2002;94:1680e7
37. Malfertheiner P, Megraud F, O'Morain CA, et al. Management of Helicobacter pylori infection-The Maastricht IV/ Florence Consensus Report. Gut. 2012;61(5):646-64. This important consensus arising from a meeting of 44 experts from 24 countries addresses treatment of H. pylori infection and strategies for reducing incidence of gastric adenocarcinoma secondary to H. pylori
38. Gotoda T. Endoscopic resection of early gastric cancer: the Japanese perspective. Curr Opin Gastroenterol. 2006;22(5):561
39. Soetikno R, Kaltenbach T, Yeh R, et al. Endoscopic mucosal resection for early cancers of the upper gastrointestinal tract. J Clin Oncol. 2005;23(20):4490
40. Fuccio L, Zagari RM, Eusebi LH, et al. Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? Ann Intern Med. 2009;151:121
41. Uemura N, Mukai T, Okamoto S, et al. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev. 1997;6:639
42. Lee YC, Chen TH, Chiu HM, et al.: The benefit ofmass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention. Gut 2012. This unique study reports outcomes from two time periods 1995-2003 and 2004-208 before and after a national H. pylori eradication program in Taiwan
43. Fukase K, Kato M, Kikuchi S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an openlabel, randomised controlled trial. Lancet. 2008;372:392
44. Maehata Y, Nakamura S, Fujisawa K, et al. Long-Term effect of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cancer. Gastrointest Endosc. 2012;75(1):39-46. This retrospective multicenter study reports results from longer follow-up which showed a lower rate of new gastric cancers after endoscopic mucosal resection in the patients in whom infection was eradicated compared those in whom infection persisted but only up to 5 years. With longer-Term follow-up the results were no longer significant
45. Wang J, Xu L, Shi R, et al. Gastric atrophy and intestinal metaplasia before and after Helicobacter pylori eradication: a metaanalysis. Digestion. 2011;83:253e60
46. Yanaoka K, Oka M, Ohata H, et al. Eradication of Helicobacter pylori prevents cancer development in subjects with mild gastric atrophy identified by serum pepsinogen levels. Int J Cancer. 2009;125:2697e703
47. Miki K, Morita M, Sasajima M, et al. Usefulness of gastric cancer screening using the serum pepsinogen test method. Am J Gastroenterol. 2003;98:735e9
48. Lydyard P, Grossi C: Secondary lymphoid organs and tissues. Immunology 1996
49. D'Elios MM, Amedei A, Manghetti M, et al. Impaired T-cell regulation of B-cell growth in Helicobacter pylori-related gastric low-grade MALT lymphoma. Gastroenterology. 1999;117:1105
50. Roggero E, Zucca E, Pinotti G, et al. Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue. Ann Intern Med. 1995;122:767
51. Bayerdörffer E, Neubauer A, Rudolph B, et al. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection: MALT Lymphoma Study Group. Lancet. 1995;345:1591
52. Steinbach G, Ford R, Glober G, et al. Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue: an uncontrolled trial. Ann Intern Med. 1999;131:88
53. Chen LT, Lin JT, Tai JJ, et al. Long-Term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma. J Nat l Cancer Inst. 2005;97:1345
54. Bertoni F, Conconi A, Capella C, et al. Molecular follow-up in gastric mucosa-associated lymphoid tissue lymphomas: early analysis of the LY03 cooperative trial. Blood. 2002;99:2541
55. Wündisch T, Thiede C, Morgner A, et al. Long-Term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication. J Clin Oncol. 2005;23:8018
56. Stathis A, Chini C, Bertoni F, et al. Long-Term outcome following Helicobacter pylori eradication in a retrospective study of 105 patients with localized gastric marginal zone B-cell lymphoma of MALT type. Ann Oncol. 2009;20:1086
57. Nakamura S, Sugiyama T, Matsumoto T, et al. Long-Term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan. Gut. 2012;61:507. This recent multicenter Japanese study describes the follow-up of 420 patients with low-grade MALT lymphoma for three or more years after H. pylori eradication with a 77% response
58. Zullo A, Hassan C, Cristofari F, et al. Effects of Helicobacter pylori eradication on early stage gastric mucosa-associated lymphoid tissue lymphoma. Clin Gastroenterol Hepatol. 2010;8(2):105-10
59. Kim JS, Chung SJ, Choi YS, et al. Helicobacter pylori eradication for low-grade gastric mucosa-associated lymphoid tissue lymphoma is more successful in inducing remission in distal compared to proximal disease. Br J Cancer. 2007;96:1324
60. Yepes S, Torres MM, Saavedra C, et al. Gastric mucosa-associated lymphoid tissue lymphomas and Helicobacter pylori infection: a Colombian perspective. World J Gastroenterol. 2012;18(7):685-91
61. Chen LT, Lin JT, Shyu RY, et al. Prospective Study of Helicobacter pylori Eradication Therapy in Stage I(E) High-Grade Mucosa-Associated Lymphoid Tissue Lymphoma of the Stomach. J Clin Oncol. 2001;19:4245
62. Fischbach W, Dragosics B, Kolve-Goebeler ME, et al. Primary gastric B-cell lymphoma: results of a prospective multicenter study: The German-Austrian Gastrointestinal Lymphoma Study Group. Gastroenterology. 2000;119:1191
63. Ruskone-Fourmestraux A, Lavergne A, Aegerter PH, et al. Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment. Gut. 2001;48:297
64. Kuo SH, Yeh KH, Wu MS, et al. Helicobacter pylori eradication therapy is effective in the treatment of early-stage H pyloripositivegastric diffuse large B-cell lymphomas. Blood. 2012;119 (21):4838-44
65. Velin D, Narayan S, Bernasconi E, et al. PAR2 promotes vaccineinduced protection against Helicobacter infection in mice. Gastroenterology. 2011;141(4):1273-82
66. Zhang JY, Liu T, Guo H, et al. Induction of a Th17 cell response by Helicobacter pylori Urease subunit B. Immunobiology. 2011;216 (7):803-10
67. Moss SF, Moise L, Lee DS, et al. HelicoVax: Epitope-based therapeutic H. pylori vaccination in a mouse model. Vaccine. 2011;29(11):2085-91
68. Wang L, Liu XF, Yun S, et al. Protection against Helicobacter pylori infection by a trivalent fusion vaccine based on a fragment of urease B-UreB414. J Microbiol (South Korea). 2010;48 (2):223-8
69. Bauer B, Meyer TF: The Human Gastric Pathogen Helicobacter pylori and Its Association with Gastric Cancer and Ulcer Disease. Ulcers 2011. doi:10.1155/2011/340157.